In fact, analyses of 581 human samples of Basal-like tumors [St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [61]] by Kaplan-Meier plotter based on RFS (Relapse Free Survival) [62], showed that high expression of Cyr61 was significantly associated to lower probability of RFS (Figure 6B). This evidence concerns the gene CCN1 and breast carcinoma.